• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Best Managed Accounts
  • Forex Robots
  • Forex Brokers
  • Forex Signals
  • Social Trading Platforms

Forex Traders Guide

The Ultimate Forex Knowledge Base

  • Robots
  • Start Guide
  • Glossary
  • Basics
    • Currency Pairs
    • Charts
    • Candlesticks
    • Trading Tips
  • Strategies
    • Technical Analysis
    • Fundamental Analysis
    • Day Trading
    • Scalping
    • Swing Trading
    • Trend Following
  • News
  • Reviews
    • Forex Robots
    • Forex Brokers
  • Mustreads
  • Crypto Trading

Promising Results for Novo Nordisk’s Obesity Drug

August 9, 2023 by Forex Winner Leave a Comment

Novo Nordisk, a Danish pharmaceutical company, saw its shares rise by 16% after the announcement of positive results from a five-year study on its obesity drug. The study revealed that the drug, marketed as Wegovy, reduces the risk of major adverse cardiovascular events in overweight or obese adults by 20%.

Semaglutide, the active component of Wegovy, proved to have a safe and well-tolerated profile during the trial. Furthermore, it demonstrated a statistically significant and superior reduction in cardiovascular events compared to the control group. The trial involved 17,604 overweight or obese adults over the age of 45 with established cardiovascular disease but no prior history of diabetes.

The results are particularly encouraging as there are currently no approved weight management medications that effectively reduce the risk of heart attack, stroke, or cardiovascular death while managing weight. Martin Holst Lange, the executive vice president for Development at Novo Nordisk, expressed excitement about these findings, stating that semaglutide 2.4 mg shows promise in reducing cardiovascular events.

Novo Nordisk plans to seek regulatory approvals for an expansion of the label indication for semaglutide 2.4 mg in the U.S. and the EU in 2023. This development opens up new possibilities for individuals struggling with obesity and related cardiovascular risks.

Best Forex Robots ›

Compare leading trading systems on the market

Filed Under: Forex News Tagged With: cardiovascular events, obesity, semaglutide, Wegovy, weight management

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Best Forex Robots

  1. Techberry 8.7
  2. Happy Forex 8.0
  3. Forex Fury 7.7
  4. Promax Gold EA 6.8
  5. Gump EA 6.4

Best Forex Brokers

  1. Techberry 8.7
  2. XM 8.2
  3. eToro 8.1
  4. Pepperstone 8.1
  5. IG 8.0

Latest News

Y2K Fashion and a Familiar Tech Rally

September 28, 2023

Bionomics Reports Successful Study of Lead Drug Candidate in PTSD

September 28, 2023

Disinflation Trend Persists, New Measures of Inflation Show

September 28, 2023

Footer

Forex Broker Reviews

OctaFX Broker

OctaFX Review

January 24, 2020 By Forex Winner

Kodi Kai Trades Review

May 28, 2023 By Andre

Trading 212

Trading 212 Review

April 25, 2019 By Forex Winner

Forex Robot Reviews

Earn2Trade Review

August 20, 2023 By Andre

FundedNext Review

August 16, 2023 By Andre

Topstep Forex Review

August 14, 2023 By Andre

EMAIL NEWSLETTER

Sign up to receive exclusive forex trading guides and insights from our team of experts!

Copyright © 2023 · Forex Traders Guide · About Us · Contact Us
Privacy Policy · Risk Disclosure